Hepatitis C virus infection among a cohort of Victorian injecting drug users.
about
Hepatitis C and injecting drug use in prisonsHepatitis C virus infection influences the S-methadone metabolite plasma concentrationLong-term effects of methadone maintenance treatment with different psychosocial intervention modelsA review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users.Epidemiology of hepatitis C virus infection among injecting drug users in Australia.Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.Risk factors for hepatitis C virus infection among injecting drug users in SydneyHepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected samplingSubstance use and hepatitis C: an ecological momentary assessment study.Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia.Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users.Spread of bloodborne viruses among Australian prison entrantsEstablishing the Melbourne Injecting Drug User Cohort Study (MIX): rationale, methods, and baseline and twelve-month follow-up resultsHepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenanceNeedle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
P2860
Q27486890-7AC1FA2F-83BB-4846-8FFF-3B697350CBBDQ28534782-9237D573-52DA-4FC7-AEB4-5E1C4EC71BB2Q28539468-04759C4F-3FB3-4F70-9429-D3EFB7C7DD85Q33256564-8E2D34E3-4052-495E-A37D-B4E3A2B08361Q33704770-3646360B-B85A-43B4-8AB0-872B7F9493F3Q33825988-8C461D4E-4450-4BD4-AB7A-7D36DAA6059FQ33934996-E0B49041-97D2-41F9-894C-B80463AD0D57Q34870882-3C0C4D5F-FED6-47EE-A574-DBCFB5F3794EQ35572940-91B9F092-F71C-4742-A566-472BD4D409BDQ36073120-41E92502-38CE-4838-B632-9BA08934788FQ36272388-4C83A228-BA23-4A98-ABE4-97D7AF1E1268Q36272393-95DC7CEF-55F4-4216-B4BC-6E6697864D57Q36535234-75457AFA-C0DD-42EC-BB0A-B95FE6EF9868Q36902176-7CC98F4F-51B2-4B9A-977F-17E61F45F4EFQ36952990-3D8AB4AF-9869-4342-A77E-9BFE81B439C9Q37011167-7516CDF8-5865-4906-9892-32E9F6278DBBQ42720607-DEF736BD-C467-40F9-8CE1-EC55D3E172CE
P2860
Hepatitis C virus infection among a cohort of Victorian injecting drug users.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Hepatitis C virus infection among a cohort of Victorian injecting drug users.
@en
Hepatitis C virus infection among a cohort of Victorian injecting drug users.
@nl
type
label
Hepatitis C virus infection among a cohort of Victorian injecting drug users.
@en
Hepatitis C virus infection among a cohort of Victorian injecting drug users.
@nl
prefLabel
Hepatitis C virus infection among a cohort of Victorian injecting drug users.
@en
Hepatitis C virus infection among a cohort of Victorian injecting drug users.
@nl
P2093
P1476
Hepatitis C virus infection among a cohort of Victorian injecting drug users.
@en
P2093
P304
P407
P577
1993-08-01T00:00:00Z